Body / AbdominalEducationTrainee
Managing PI-RADS 3 Prostate MRI Lesions: Reducing Uncertainty and Refining Biopsy Decisions
Radiographics : a review publication of the Radiological Society of North America, Inctoday
Structured reporting, reader experience, image quality, and prostate-specific antigen (PSA) density can reduce uncertainty in PI-RADS 3 prostate MRI lesions, guiding biopsy decisions for clinically significant cancer.
- PI-RADS 3 rates rise with suboptimal image quality, postprocedural changes, noncontrast MRI, and less-experienced readers.
- Strategies include using structured reporting, PI-RADS decision rules, reader training, image quality assessment, and patient preparation.
- Integrating prostate-specific antigen (PSA) density into risk-based pathways refines biopsy decisions.
Related reporting systems
Automated summary
RadPigeon summaries are original and for information only. They are not clinical advice.